Cross Country Healthcare, Inc. (CCRN) Price Target Analysis
Updated Jun 18, 2026
Analyst Rating: Hold
Based on 14 analysts5.1% Above Target
CCRN trades 5.1% above Wall Street's consensus target of $12.50.
Current Price$13.17
Average Target$12.50
Target
Current
Low$11.00
Median$12.50
High$14.00
Analyst Target Range
Forward P/E142.4x
(High Premium)
PEG Ratio—
Implied Growth+103.0%
(High Growth)
Analyst Spread24.0%
(High Agreement)
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Consensus Scenario Assumptions
The base valuation assumes CCRN achieves its forward estimates and maintains a stable P/E multiple of 142.4x. This scenario reflects the blended consensus of 14 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
CCRN Price Target Analysis
Updated June 21, 2026As of June 21, 2026, Cross Country Healthcare, Inc. (CCRN) has a Wall Street consensus price target of $12.50, based on estimates from 14 covering analysts. With the stock currently trading at $13.17, this represents a potential downside of -5.1%. The company has a market capitalization of $426M.
Analyst price targets range from a low of $11.00 to a high of $14.00, representing a 24% spread in expectations. The median target of $12.50 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 2 analysts rating the stock as a Buy or Strong Buy,12 rating it Hold, and 0 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, CCRN trades at a trailing P/E of -4.5x and forward P/E of 142.4x. Analysts expect EPS to grow +103.0% over the next year.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside
+9.3%
Industry Consensus
Avg Forward P/E
13.5x
(Value)
Peers with Coverage
10 / 10
Active Analyst Tracking
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 AMNAMN Healthcare Services, Inc. | $1.2B | $30.98 | $27.00 | -12.8% | Buy | 11.6x | 17 |
 TBITrueBlue, Inc. | $203M | $6.70 | $5.50 | -17.9% | Buy | — | 10 |
 HCSGHealthcare Services Group, Inc. | $1.6B | $22.94 | $24.50 | +6.8% | Hold | 21.2x | 15 |
 KELYAKelly Services, Inc. | $394M | $11.36 | $15.00 | +32.0% | Buy | 12.6x | 5 |
 MANManpowerGroup Inc. | $1.6B | $33.55 | $37.86 | +12.8% | Hold | 9.1x | 29 |
 ASGNASGN Incorporated | $895M | $20.96 | $37.60 | +79.4% | Hold | 5.8x | 13 |
 KFYKorn Ferry | $3.7B | $71.46 | $75.00 | +5.0% | Buy | 13.4x | 11 |
 HIMSHims & Hers Health, Inc. | $7.8B | $35.47 | $28.08 | -20.8% | Hold | — | 20 |
 PINCPremier, Inc. | $2.3B | $28.26 | $33.15 | +17.3% | Hold | 20.8x | 31 |
 TDOCTeladoc Health, Inc. | $1.5B | $8.07 | $7.40 | -8.3% | Hold | — | 42 |
CCRN — Frequently Asked Questions
Quick answers to the most common questions about buying CCRN stock.
What is the CCRN stock price target for 2026?
Wall Street's consensus price target for CCRN is $12.5, -5.1% from its current price of $13.17. The below-market target from 14 analysts suggests limited near-term appreciation.
Is CCRN a buy, sell, or hold?
CCRN has a consensus rating of "Hold" based on 14 Wall Street analysts. The rating breakdown is mixed, with 12 Hold ratings making up the largest segment. The consensus 12-month price target of $12.5 implies -5.1% downside from current levels.
Is CCRN stock overvalued or undervalued?
At a forward P/E of 142.3784x, CCRN trades at a premium valuation. The consensus price target of $12.5 (-5.1% downside) suggests analysts may view current valuations as stretched.
How high can CCRN stock go?
The most bullish Wall Street analyst has a price target of $14 for CCRN, while the most conservative target is $11. The consensus of $12.5 represents the median expectation. These targets typically reflect 12-month expectations.
How many analysts cover CCRN stock?
CCRN is moderately covered, with 14 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 2 have Buy ratings, 12 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the CCRN stock forecast?
The 12-month CCRN stock forecast based on 14 Wall Street analysts shows a consensus price target of $12.5, with estimates ranging from $11 (bear case) to $14 (bull case). The median consensus rating is "Hold".
What is CCRN's forward P/E ratio?
CCRN trades at a forward P/E ratio of 142.4x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy CCRN stock?
Analysts are cautious on CCRN, with 0 Sell ratings and a price target of $12.5 (-5.1% from current price). The "Hold" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do CCRN price targets vary so much?
CCRN analyst price targets range from $11 to $14, a 24% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $12.5 consensus represents the middle ground.
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare